Inflammation and increased IDO in hippocampus contribute to depression-like behavior induced by estrogen deficiency

Behavioural Brain Research

Volumn 288, Issue , 2015, Pages 71-78

  Xu, Yongjun ^a   Sheng, Hui ^a   Tang, Zhiping ^b   Lu, Jianqiang ^b   Ni, Xin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF SPORT   (China)

Author keywords

Depression; Estrogen; Indoleamine 2,3 dioxygenase (IDO); Inflammation

Indexed keywords

ESTROGEN; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; SEROTONIN; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; ANTIDEPRESSANT AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; NUCLEOCYTOPLASMIC TRANSPORT PROTEIN; P65 ONCOFETAL MRNA TRANSPORT PROTEIN, RAT; TLR4 PROTEIN, RAT; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME ACTIVATION; ESTROGEN BLOOD LEVEL; ESTROGEN DEFICIENCY; FEMALE; HIPPOCAMPUS; INFLAMMATION; NONHUMAN; OPEN FIELD TEST; OVARIECTOMY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RAT MODEL; SUGAR INTAKE; TAIL SUSPENSION TEST; TISSUE DISTRIBUTION; UPREGULATION; UTERUS WEIGHT; WEIGHT GAIN; ANIMAL; BLOOD; DEFICIENCY; DEPRESSIVE DISORDER; DRUG EFFECTS; METABOLISM; PSYCHOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; ESTROGENS; FEMALE; HIPPOCAMPUS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-6; NEOPLASM PROTEINS; NF-KAPPA B; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; OVARIECTOMY; PREFRONTAL CORTEX; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; SEROTONIN; TOLL-LIKE RECEPTOR 4;

EID: 84928572182     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2015.04.017     Document Type: Article

References (52)

1. Kessler R.C., McGonagle K.A., Swartz M., Blazer D.G., Nelson C.B. Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J Affect Disord 1993, 29:85-96.
2. Earls F. Sex differences in psychiatric disorders: origins and developmental influences. Psychiatr Dev 1987, 5:1-23.
3. Becker J.B., Monteggia L.M., Perrot-Sinal T.S., Romeo R.D., Taylor J.R., Yehuda R., et al. Stress and disease: is being female a predisposing factor. J Neurosci 2007, 27:11851-11855.
4. Dalla C., Antoniou K., Kokras N., Drossopoulou G., Papathanasiou G., Bekris S., et al. Sex differences in the effects of two stress paradigms on dopaminergic neurotransmission. Physiol Behav 2008, 93:595-605.
5. Freeman E.W. Associations of depression with the transition to menopause. Menopause 2010, 17:823-827.
6. Ahokas A., Kaukoranta J., Wahlbeck K., Aito M. Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study. J Clin Psychiatry 2001, 62:332-336.
7. Walf A.A., Frye C.A. A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 2006, 31:1097-1111.
8. Kiss A., Delattre A.M., Pereira S.I., Carolino R.G., Szawka R.E., Anselmo-Franci J.A., et al. 17β-estradiol replacement in young, adult and middle-aged female ovariectomized rats promotes improvement of spatial reference memory and an antidepressant effect and alters monoamines and BDNF levels in memory- and depression-related brain areas. Behav Brain Res 2012, 227:100-108.
9. Eyre H., Baune B.T. Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology 2012, 37:1397-1416.
10. Streit W.J., Mrak R.E., Griffin W.S. Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation 2004, 1:14.
11. Gárate I., García-Bueno B., Madrigal J.L., Bravo L., Berrocoso E., Caso J.R., et al. Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression. J Neuroinflammation 2011, 8:151.
12. Goshen I., Kreisel T., Ben-Menachem-Zidon O., Licht T., Weidenfeld J., Ben-Hur T., et al. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry 2008, 13:717-728.
13. Shelton R.C., Claiborne J., Sidoryk-Wegrzynowicz M., Reddy R., Aschner M., Lewis D.A., et al. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry 2011, 16:751-762.
14. Anisman H. Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci 2009, 34:4-20.
15. Raison C.L., Borisov A.S., Majer M., Drake D.F., Pagnoni G., Woolwine B.J., et al. Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol Psychiatry 2009, 65:296-303.
16. Dobos N., de Vries E.F., Kema I.P., Patas K., Prins M., Nijholt I.M., et al. The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression. J Alzheimers Dis 2012, 28:905-915.
17. Sublette M.E., Postolache T.T. Neuroinflammation and depression: the role of indoleamine 2,3-dioxygenase (IDO) as a molecular pathway. Psychosom Med 2012, 74:668-672.
18. Schiepers O.J., Wichers M.C., Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:201-217.
19. Neumeister A. Tryptophan depletion, serotonin, and depression: where do we stand. Psychopharmacol Bull 2003, 37:99-115.
20. Myint A.M., Kim Y.K. Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses 2003, 61:519-525.
21. O'Connor J.C., Lawson M.A., André C., Moreau M., Lestage J., Castanon N., et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 2009, 14:511-522.
22. Lee S., Jeong J., Kwak Y., Park S.K. Depression research: where are we now?. Mol Brain 2010, 3:8.
23. Arevalo M.A., Diz-Chaves Y., Santos-Galindo M., Bellini M.J., Garcia-Segura L.M. Selective oestrogen receptor modulators decrease the inflammatory response of glial cells. J Neuroendocrinol 2012, 24:183-190.
24. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1997, Elsevier, San Diego. 3rd edition.
25. Willner P., Towell A., Sampson D., Sophokleous S., Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 1987, 93:358-364.
26. Zheng H., Liu Y., Li W., Yang B., Chen D., Wang X., et al. Beneficial effects of exercise and its molecular mechanisms on depression in rats. Behav Brain Res 2006, 168:47-55.
27. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985, 85:367-370.
28. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
29. Walf A.A., Frye C.A. Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats. Pharmacol Biochem Behav 2007, 86:407-414.
30. Walf A.A., Frye C.A. Antianxiety and antidepressive behavior produced by physiological estradiol regimen may be modulated by hypothalamic-pituitary-adrenal axis activity. Neuropsychopharmacology 2005, 30:1288-1301.
31. Walf A.A., Paris J.J., Frye C.A. Chronic estradiol replacement to aged female rats reduces anxiety-like and depression-like behavior and enhances cognitive performance. Psychoneuroendocrinology 2009, 34:909-916.
32. Hiroi R., Handa R.J. Estrogen receptor-β regulates human tryptophan hydroxylase-2 through an estrogen response element in the 5' untranslated region. J Neurochem 2013, 127:487-495.
33. Sánchez M.G., Morissette M., Di Paolo T. Estradiol and brain serotonin reuptake transporter in long-term ovariectomized parkinsonian monkeys. Prog Neuropsychopharmacol Biol Psychiatry 2013, 45:170-177.
34. Maes M., Leonard B.E., Myint A.M., Kubera M., Verkerk R. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:702-721.
35. Gorina R., Font-Nieves M., Márquez-Kisinousky L., Santalucia T., Planas A.M. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways. Glia 2011, 59:242-255.
36. Liu W., Sheng H., Xu Y., Liu Y., Lu J., Ni X. Swimming exercise ameliorates depression-like behavior in chronically stressed rats: relevant to proinflammatory cytokines and IDO activation. Behav Brain Res 2013, 242:110-116.
37. Farooq R.K., Isingrini E., Tanti A., Le Guisquet A.M., Arlicot N., Minier F., et al. Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation. Behav Brain Res 2012, 231:130-137.
38. Vegeto E., Ghisletti S., Meda C., Etteri S., Belcredito S., Maggi A. Regulation of the lipopolysaccharide signal transduction pathway by 17beta-estradiol in macrophage cells. J Steroid Biochem Mol Biol 2004, 91:59-66.
39. Sárvári M., Hrabovszky E., Kalló I., Solymosi N., Tóth K., Likó I., et al. Estrogens regulate neuroinflammatory genes via estrogen receptors α and β in the frontal cortex of middle-aged female rats. J Neuroinflammation 2011, 8:82.
40. LaPlant Q., Chakravarty S., Vialou V., Mukherjee S., Koo J.W., Kalahasti G., et al. Role of nuclear factor kappaB in ovarian hormone-mediated stress hypersensitivity in female mice. Biol Psychiatry 2009, 65:874-880.
41. Chakrabarti M., Haque A., Banik N.L., Nagarkatti P., Nagarkatti M., Ray S.K. Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration. Brain Res Bull 2014, 109:22-31.
42. Hu X., Qin X. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice. Int J Mol Med 2013, 31:1209-1221.
43. O'Connor J.C., Andre C., Wang Y.X., Lawson M.A., Szegedi S.S., Lestage J., et al. Interferon-γ and tumor necrosis factor-α mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guérin. J Neurosci 2009, 29:4200-4209.
44. Connor T.J., Starr N., O'Sullivan J.B., Harkin A. Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFNγ. Neurosci Lett 2008, 441:29-34.
45. Wang Y., Lawson M.A., Dantzer R., Kelley K.W. LPS-induced indoleamine 2,3-dioxygenase is regulated in an interferon-gamma-independent manner by a JNK signaling pathway in primary murine microglia. Brain Behav Immun 2010, 24:201-209.
46. Yang F., Tao J., Xu L., Zhao N., Chen J., Chen W., et al. Estradiol decreases rat depressive behavior by estrogen receptor beta but not alpha: no correlation with plasma corticosterone. NeuroReport 2014, 25:100-104.
47. McCormick C.M., Linkroum W., Sallinen B.J., Miller N.W. Peripheral and central sex steroids have differential effects on the HPA axis of male and female rats. Stress 2002, 5:235-247.
48. Tanti A., Belzung C. Open questions in current models of antidepressant action. Br J Pharmacol 2010, 159:1187-1200.
49. Pfaff D., Keiner M. Atlas of estradiol-concentrating cells in the central nervous system of the female rat. J Comp Neurol 1973, 151:121-158.
50. Lu J., Xu Y., Hu W., Gao Y., Ni X., Sheng H., et al. Exercise ameliorates depression-like behavior and increases hippocampal BDNF level in ovariectomized rats. Neurosci Lett 2014, 573:13-18.
51. Diel P. Tissue-specific estrogenic response and molecular mechanisms. Toxicol Lett 2002, 127:217-224.
52. Smith C.L., O'Malley B.W. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 2004, 25:45-71.